tirzepatide vs dulaglutide Officially published, (#Mounjaro) (#Trulicity) in those with type 2 #diabetes and established heart disease. Several years ago, dulaglutide was shown to reduce the risk of heart attacks, strokes and tirzepatide cardiovascular outcome Cardiovascular Outcomes

Additionally, semaglutide may enhance insulin sensitivity, helping your body use glucose more efficientlya benefit that extends beyond weight management to overall metabolic health

Measurements in vivo : IOP and fundoscopy

The SURMOUNT trials, which studied tirzepatide's effectiveness in weight management, followed thousands of participants over 72 weeks

Research indicates the combination produces synergistic GH release greater than either peptide administered alone: CJC-1295 amplifies the GH pulse

For patients who want more aggressive results or who have not responded optimally to semaglutide, tirzepatide is a powerful step up